Hims & Hers CEO Defends Telehealth Model Amid FTC Lawsuit

The Federal Trade Commission, together with Los Angeles County and Utah, has filed a lawsuit against Hims & Hers, alleging that the telehealth firm shared user health information with advertisers such as Meta and Snap, charged for prescriptions before patients spoke with a healthcare provider, and made subscription cancellations difficult. The complaint characterizes these practices as violations of consumer-protection rules.

CNBC

The lawsuit, announced in July, targets the company’s digital-first approach to delivering prescription medication and other health services. Critics argue that the model blurs the line between medical care and advertising, while the firm positions itself as a “digital ecosystem” that seeks to remodel traditional healthcare delivery. The FTC’s action follows a broader regulatory focus on data privacy and consumer rights in the rapidly expanding telehealth sector.

CNBC

In an exclusive interview on CNBC’s “Squawk Box,” Hims & Hers chief executive Andrew Dudum framed the allegations as a misunderstanding of the company’s disruptive mission.

CNBC

• “We are active disruptors. We take that head on, and we're willing to do it. But it is always when we believe that it's in the best interest of people and their access,” — Andrew Dudum, hers CEO

CNBC